始立膜衣錠100/25/200毫克
Land: Taívan
Tungumál: kínverska
Heimild: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Upplýsingar fylgiseðill
(PIL)
05-06-2021
Opinber matsskýrsla
(PAR)
04-06-2020
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
ENTACAPONE;;LEVODOPA;;CARBIDOPA MONOHYDRATE
Fáanlegur frá:
美時化學製藥股份有限公司 台北市信義區松仁路277號17樓 (11456110)
ATC númer:
N04BA03
Lyfjaform:
膜衣錠
Samsetning:
LEVODOPA (1208002900) MG; ENTACAPONE (1208008800) MG; CARBIDOPA MONOHYDRATE (2408000420) MG
Einingar í pakka:
塑膠瓶裝
Tegund:
製 劑
Gerð lyfseðils:
須由醫師處方使用
Framleitt af:
Orion Corporation Joensuunkatu 7, Salo 24100, Finland FI
Lækningarsvæði:
levodopa, decarboxylase inhibitor and COMT inhibitor
Ábendingar:
表現藥效終期運動功能波動現象，以左多巴/多巴脫羧基脢抑制劑無法達到穩定治療效果之巴金森氏症病人。
Vörulýsing:
有效日期: 2025/03/09; 英文品名: STALEVO FILM-COATED TABLETS 100/25/200MG
Leyfisdagur:
2005-03-09
Upplýsingar fylgiseðill
COPYRIGHTS / CONTACT
This artwork and its content is copyright of Alvogen
©Alvogen 2012. All rights reserved.
Any Anthropoidea digitally or hardcopy redistribution,
alternation or reproduction of part or all of the contents in
any form is prohibited by other than Alvogen staff for
company usage.
MAIN CONTACT:
David Garcia, Artwork Director
david.garcia@Alvogen.com
PRINT COLOURS
Black
Black 80%
Black 20%
PMS 485 C
SUPPORT COLOURS (NO PRINT)
Die Cut
..
LEVOD_CARBID_ENTACAP TAIWAN
100_25_200MG FCT PIL
Die Cut size
Created
Modified
Proof round
ART Code
177x600mm
RE 12/06/2020
RE 17/07/2020
05
ARTDB018115P
MINIMUM FONT SIZE = 9PT
IF THE ABOVE MINIMUM FONT SIZE IS NOT
ACCEPTABLE FOR THIS ARTWORK (EXCLUDING
CODES) PLEASE DO NOT APPROVE.
REGULATORY APPROVAL
Pharmacode
Pharmacode
膜衣錠 50/12.5/200 毫克
衛署藥輸字第024173號
膜衣錠 100/25/200 毫克
衛署藥輸字第024171號
膜衣錠 150/37.5/200 毫克
衛署藥輸字第024172號
STALEVO
®
Film-coated Tablets 50/12.5/200 mg
100/25/200 mg
150/37.5/200 mg
成分及製劑含量
每粒
Stalevo
50/12.5/200
毫克膜衣錠含
levodopa
50
毫克，
carbidopa 12.5
毫克及
entacapone 200
毫克，外觀為棕色或
紅灰色圓形、雙凸面錠劑，一面刻有
”LCE 50”
字樣。
每粒
Stalevo 100/25/200
毫克膜衣錠含
levodopa 100
毫克，
carbidopa 25
毫克及
entacapone 200
毫克，外觀為棕色或紅
灰色卵圓形錠劑，一面刻有
”LCE 100”
字樣。
每粒
Stalevo 150/37.5/200
毫克膜衣錠含
levodopa 150
毫克，
carbidopa 37.5
毫克及
entacapone 200
毫克，外觀為棕色或
紅灰色長橢圓形錠劑，一面刻有
”LCE 150”
字樣。
賦形劑組成請參考“賦形劑”說明。
適應症
表現藥效終期運動功能波動現象，以左多巴
/
多巴脫羧基
酶抑制劑無法達到穩定治療效果之巴金森氏症病人。
用法用量
本藥須由醫師處方使用
理想的每日劑量需透過小心標定每位病人的
levodopa
來
決定，每日劑量最好是從可利用的三種不同含量
Lestu allt skjalið
